Ardent Health Partners (ARDT) to Release Earnings on Wednesday

Ardent Health Partners (NYSE:ARDTGet Free Report) is anticipated to release its earnings data before the market opens on Wednesday, February 5th. Analysts expect Ardent Health Partners to post earnings of $0.45 per share for the quarter. Ardent Health Partners has set its FY 2024 guidance at 1.230-1.370 EPS.Parties that wish to listen to the company’s conference call can do so using this link.

Ardent Health Partners (NYSE:ARDTGet Free Report) last issued its quarterly earnings data on Wednesday, November 6th. The company reported $0.19 EPS for the quarter, missing analysts’ consensus estimates of $0.29 by ($0.10). The company had revenue of $1.45 billion for the quarter, compared to analysts’ expectations of $1.46 billion. On average, analysts expect Ardent Health Partners to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Ardent Health Partners Stock Performance

Shares of ARDT opened at $14.74 on Wednesday. Ardent Health Partners has a 12-month low of $13.63 and a 12-month high of $20.72. The company has a quick ratio of 1.78, a current ratio of 1.91 and a debt-to-equity ratio of 0.78. The business’s 50-day simple moving average is $15.93.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on ARDT shares. Truist Financial reduced their target price on Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. KeyCorp began coverage on Ardent Health Partners in a report on Friday, October 11th. They issued an “overweight” rating and a $24.00 price target for the company. Morgan Stanley decreased their price objective on Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 21st. Bank of America cut Ardent Health Partners from a “buy” rating to a “neutral” rating and dropped their price objective for the stock from $22.00 to $19.00 in a research report on Wednesday, November 6th. Finally, JPMorgan Chase & Co. restated a “neutral” rating and issued a $20.00 target price on shares of Ardent Health Partners in a report on Tuesday, December 17th. Two research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of $21.55.

Get Our Latest Analysis on ARDT

About Ardent Health Partners

(Get Free Report)

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.

Read More

Receive News & Ratings for Ardent Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.